EUVIMEDEUVIMED entdecken
Crossref

Establishing validity of a novel patient-centered and directly measurable definition of acute exacerbation of chronic rhinosinusitis

F A Houssein, A R Sedaghat, K M Phillips

Rhinology Journal · 2025

DOI: 10.4193/rhin24.378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rhinology Journal, 2025. Verfasst von F A Houssein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngologyâ€"Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A patient-centered and directly measurable definition for acute exacerbation of chronic rhinosinusitis (AECRS) has been developed as “a flare up of symptoms beyond day-to-day variation, lasting at least 3 days, and to which a distinct negative impact on a patient’s quality of life (QOL) or functionality can be attributed”. Our aim is to understand how this definition correlates with previously used metrics. Methodology: Cross-sectional study of chronic rhinosinusitis (CRS) patients. The number of AECRS (using this novel definition), courses of CRS-related systemic antibiotics and corticosteroids taken for these AECRS, and number of asthma exacerbations in the past 6 months was queried. Disease-specific quality of life was measured using the 22-item Sinonasal Outcome Test.

Results

A total of 237 CRS patients were enrolled. In the 6-month period prior to study enrollment, the mean number of AECRS was 4.2 while the mean number of systemic antibiotics or corticosteroids taken for these AECRS was 1.6 reflecting patients received rescue medication for 33% of AECRS. The number of AECRS was weakly correlated with number of systemic rescue medications and SNOT-22 score. For asthmatic CRS patients, numbers of AECRS and asthma exacerbations were correlated. Finally, comorbidities were associated with higher AECRS frequency by 29% in migraine and 41% in active tobacco users.

Conclusions

We achieved our aim by showing the AECRS definition correlates with systemic rescue medication usage, disease-specific QOL and asthma exacerbations. Our results demonstrate that indirect measures of AECRS may not capture all AECRS. Furthermore, comorbid migraine and tobacco use are associated with AECRS frequency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisHumansCross-Sectional StudiesChronic DiseaseQuality of LifeMaleFemaleMiddle AgedAnti-Bacterial AgentsAdultDisease ProgressionAsthmaAdrenal Cortex HormonesSymptom Flare UpAgedAcute DiseaseRhinosinusitis

Substanzen

Anti-Bacterial AgentsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Otolaryngologyâ€"Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Zitieren

APA

Houssein, F. A., Sedaghat, A. R., & Phillips, K. M. (2025). Establishing validity of a novel patient-centered and directly measurable definition of acute exacerbation of chronic rhinosinusitis. Rhinology Journal. https://doi.org/10.4193/rhin24.378

Vancouver

Houssein FA, Sedaghat AR, Phillips KM. Establishing validity of a novel patient-centered and directly measurable definition of acute exacerbation of chronic rhinosinusitis. Rhinology Journal. 2025. doi:10.4193/rhin24.378

BibTeX
@article{Houssein2025,
  author = {Houssein, F A and Sedaghat, A R and Phillips, K M},
  title = {Establishing validity of a novel patient-centered and directly measurable definition of acute exacerbation of chronic rhinosinusitis},
  journal = {Rhinology Journal},
  year = {2025},
  doi = {10.4193/rhin24.378}
}
Kostenlos starten →